NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Updated August 1, 2026

Supplement × Prescription·Evidence index

Simvastatin and Vitamin B3: what the published research says

PubMed indexes 7 records that name Simvastatin and Vitamin B3 together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.

Read this first

An evidence index, not guidance.

Every statement below is attributed to a named, dated, linked source.

This page lists published research relevant to Simvastatin and Vitamin B3. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.

The research

7 studies naming Simvastatin and Vitamin B3.

Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.

A new paradigm for managing dyslipidemia with combination therapy: laropiprant + niacin + simvastatin.

Expert opinion on investigational drugs · 2010 · PMID 20141348

ReviewHuman subjects

“Readers will understand both the mechanism and clinical effects of the combination therapy of simvastatin/ER niacin/laropiprant. The triple combination therapy of simvastatin/ER niacin/laropiprant may reduce flushing side effects and facilitate a more comprehensive treatment for patients with mixed dyslipidemia.”

Yiu et al. · From the abstract

Names both Simvastatin and Vitamin B3 in its title.

Niacin extended-release/simvastatin.

Drugs · 2008 · PMID 18973399

ReviewHuman subjects

“However, plasma HDL-C levels increased more and triglyceride levels were lowered more than with simvastatin monotherapy (SEACOAST I and II). Niacin ER/simvastatin was generally well tolerated, with flushing being the most common adverse reaction.”

Sanford et al. · From the abstract

Names both Simvastatin and Vitamin B3 in its title.

Safety of niacin and simvastatin combination therapy.

The American journal of cardiology · 2008 · PMID 18375239

ReviewHuman subjects

“Because niacin and statins have complementary lipid effects and because individually, niacin and statins have been shown in outcomes studies to reduce atherosclerotic coronary artery disease events, the combined use of these 2 agents has significant potential to not only improve the lipid values of patients but improve their lives as well.”

Bays · From the abstract

Names both Simvastatin and Vitamin B3 in its title.

Simvastatin and niacin.

Current cardiology reports · 2002 · PMID 12379170

Names both Simvastatin and Vitamin B3 in its title.

Comparison table: Some lipid-lowering drugs.

The Medical letter on drugs and therapeutics · 2019 · PMID 30845107

Comparative StudyHuman subjects

Names Simvastatin and Vitamin B3 together in an interaction, co-administration, or pharmacokinetic context.

Limitations

What this evidence cannot tell you.

Search-based evidence indexes have real limits, and it is worth being explicit about them:

NutriStack

Track what you actually take.

NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Simvastatin, Vitamin B3, and several hundred other substances.

The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.